NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-182-2017-0-ES-01 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION ES EP 18786145.5 Issued
NCI E-182-2017-0-CH-01 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION CH EP 18786145.5 Issued
NCI E-182-2017-0-EP-06 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION EP National Stage 18786145.5 Issued
NCI E-182-2017-0-GB-01 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION GB EP 18786145.5 Issued
NIAID E-087-2019-0-PCT-01 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE PCT PCT COMB PCT/US2020/031345 Expired
NIAID E-087-2019-0-EP-02 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE EP National Stage 20727798.9 Pending
NCI E-038-2018-0-JP-07 COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-ROR1 IMMUNOTHERAPY JP National Stage 2020-524450 Issued
NIDCR E-485-2013-1-US-04 COMPOSITIONS AND METHODS FOR THE INHIBITION OF PRURITUS US National Stage 16/761,047 11324725 Issued PDF
NIAID E-198-2025-0-US-01 VIRAL SEROLOGY ASSAYS US 63/018,893 Expired
NCI E-167-2017-0-AU-03 CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY AU National Stage 2018360784 Abandoned
NHLBI E-121-2016-2-US-09 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE US National Stage 16/760,760 12516292 Issued PDF
NCATS E-098-2019-0-PCT-02 SCALABLE SYNTHESIS OF DUAL-TARGET INHIBITOR OF CANNABINOID-1 RECEPTOR AND INDUCIBLE NITRIC OXIDE SYNTHASE PCT PCT PCT/US2020/030624 Expired
NIDCR E-150-2019-0-US-01 Application Of AAV44.9 Vector In Gene Therapy For The Inner Ear US 63/018,140 Abandoned
NCATS E-101-2017-0-US-04 SUBSTITUTED QUINOLINE ANALOGS AS ALDEHYDEDE DEHYDROGENASE 1A1 (ALDH1A1) INHIBITORS US National Stage 16/760,345 11505559 Issued PDF
NCATS E-074-2019-0-US-02 ANTI-FLAVIVIRUS COMPOUNDS AND METHODS OF USE US CON 16/861,281 11471443 Issued PDF
NCI E-167-2017-0-US-09 CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY US National Stage 16/760,138 Abandoned
NIAID E-131-2019-0-US-01 RECOMBINANT HUMAN METAPNEUMOVIRUS F PROTEINS AND THEIR USE US 63/017,581 Abandoned
NCI E-237-2017-1-KR-09 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION KR National Stage 10-2020-7012343 Issued
NCI E-237-2017-2-KR-12 T CELL RECEPTORS RECOGNIZING MUTATED P53 KR National Stage 10-2020-7012344 Issued
NCI E-182-2017-0-KR-09 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION KR National Stage 10-2020-7012314 Issued
NCI E-008-2014-2-US-15 THYMIC STROMAL LYMPHOPOIETIN RECEPTOR-SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND METHODS USING SAME US DIV 16/860,216 11834509 Issued PDF
NCI E-035-2017-0-HK-10 STAT3 INHIBITOR FORMULATION HK EP 62020006657.4 Abandoned
NCI E-125-2021-0-US-01 Methods And Materials For Large-Scale Assessment Of Ligand Binding Selectivity Of G-Quadruplex Recognition Using Custom G4 Microarrays US 63/016,385 Abandoned
NIAID E-182-2020-4-US-01 CORONAVIRUS RNA VACCINES US 63/016,175 Abandoned
NINDS E-102-2019-1-PCT-01 HIGH-RESOLUTION CEREBROSPINAL FLUID-SUPPRESSED T2*-WEIGHTED MAGNETIC RESONANCE IMAGING OF CORTICAL LESIONS PCT PCT COMB PCT/US2020/029823 Expired
NCATS E-060-2019-0-PCT-02 NOCICEPTOR DIFFERENTIATION FROM HUMAN PLURIPOTENT STEM CELLS PCT PCT PCT/US2020/029721 Expired
NCATS E-060-2019-0-EP-07 NOCICEPTOR DIFFERENTIATION FROM HUMAN PLURIPOTENT STEM CELLS EP National Stage 20796132.7 Pending
NCATS E-060-2019-0-JP-05 A Highly Efficient Nociceptor Differentiation Protocol For Human Pluripotent Stem Cells JP National Stage 2021-563214 Pending
NCATS E-060-2019-0-AU-06 NOCICEPTOR DIFFERENTIATION FROM HUMAN PLURIPOTENT STEM CELLS AU National Stage 2020263484 Pending
NHLBI E-149-2020-0-US-01 PROGRAMMABLE MECHANOBIOLOGICAL PLATFORM US 63/014,981 Abandoned
NIDDK E-144-2019-1-US-01 Treatment And Prevention Of Neuropathic Pain With P2Y14 Antagonists US 63/013,792 Abandoned
NEI E-050-2015-0-US-09 RP2 AND RPGR VECTORS FOR TREATING X-LINKED RETINITIS PIGMENTOSA US DIV 16/854,605 11617801 Issued PDF
NIAID E-136-2013-0-US-13 SINGLE-DOMAIN VHH ANTIBODIES DIRECTED TO NOROVIRUS GI.1 AND GII.4 AND THEIR USE US DIV 16/854,703 11325965 Abandoned PDF
NCI E-008-2018-0-KR-06 OPTICAL CONFIGURATION METHODS FOR SPECTRAL SCATTER FLOW CYTOMETRY KR National Stage 10-2020-7011517 Issued
NCI E-008-2018-0-JP-05 OPTICAL CONFIGURATION METHODS FOR SPECTRAL SCATTER FLOW CYTOMETRY JP National Stage 2020-522670 Issued
NHGRI E-148-2017-0-US-04 ISOTOPIC BIOMARKERS OF ORGANIC ACIDEMIAS US National Stage 16/758,009 Pending
NCI E-181-2017-0-KR-17 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS KR National Stage 10-2020-7011112 Issued
NCI E-229-2017-0-US-03 TREATING OR PREVENTING ADVERSE LIVER CONDITIONS US National Stage 16/756,926 11771737 Issued PDF
NIDDK E-108-2020-0-US-01 Thyclotides US 63/011,398 Abandoned
NIAID E-186-2020-0-US-01 Nucleic Acid Vaccines Against CoVID-19 US 63/011,860 Abandoned
NHLBI E-121-2016-2-IL-06 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE IL National Stage 273979 Issued
NCI E-230-2012-0-IL-59 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 IL DIV 274003 Issued
NIAID E-240-2017-0-US-05 RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE US National Stage 16/756,777 11136356 Issued PDF
NIAID E-203-2020-0-PCT-02 COMPOSITIONS AND METHODS OF MANUFACTURING STAR POLYMERS FOR LIGAND DISPLAY AND/OR DRUG DELIVERY PCT PCT PCT/US2020/028586 Expired
NIAID E-203-2020-0-CN-07 COMPOSITIONS AND METHODS OF MANUFACTURING STAR POLYMERS FOR LIGAND DISPLAY AND/OR DRUG DELIVERY CN National Stage 202080042939.8 Pending
NIAID E-203-2020-0-EP-08 COMPOSITIONS AND METHODS OF MANUFACTURING STAR POLYMERS FOR LIGAND DISPLAY AND/OR DRUG DELIVERY EP National Stage 20724651.3 Pending
NIAID E-203-2020-0-JP-09 COMPOSITIONS AND METHODS OF MANUFACTURING STAR POLYMERS FOR LIGAND DISPLAY AND/OR DRUG DELIVERY JP National Stage 2021-562047 Pending
NIAID E-203-2020-0-IN-05 COMPOSITIONS AND METHODS OF MANUFACTURING STAR POLYMERS FOR LIGAND DISPLAY AND/OR DRUG DELIVERY IN National Stage 202117049363 Abandoned
NIAID E-203-2020-0-AU-06 COMPOSITIONS AND METHODS OF MANUFACTURING STAR POLYMERS FOR LIGAND DISPLAY AND/OR DRUG DELIVERY AU National Stage 2020260131 Pending
NIAID E-203-2020-0-CA-03 COMPOSITIONS AND METHODS OF MANUFACTURING STAR POLYMERS FOR LIGAND DISPLAY AND/OR DRUG DELIVERY CA National Stage 3137081 Pending